International ID
Conference Coverage
Dengue disease is here and U.S. physicians need to get to know it
Know the warning signs that distinguish a case of self-limited dengue from one headed for severe and potentially fatal complications.
Conference Coverage
Promising nonvaccine approaches to controlling dengue
As dengue vaccine development stumbles, nonpesticide-based mosquito control strategies gain traction.
News
FDA approves new single-tablet HIV treatment
The U.S. Food and Drug Administration has approved the fixed-dose combination tablet Genvoya as a complete regimen for the treatment of HIV-1...
News
Zika virus adds to dengue and chikungunya threat in Brazil
Clusters of acute exanthematous illness since 2014 in Brazil have been linked to the Zika virus, but research also suggests the concurrent...
News
Louse-borne relapsing fever appears again in Europe
The reemergence of an early-20th-century fever is an example of how increased migration from war-torn and resource-poor countries has created new...
News
Early diagnosis of primary amebic meningoencephalitis key to treatment
A 2014 Florida case of primary amebic meningoencephalitis – a rare, typically fatal infection of the brain – is a reminder to physicians of the...
News
Genomic sequencing technology reveals weakness in malaria vaccine
Genetic variability in the surface protein targeted by an experimental malaria vaccine explains why the vaccine provided only moderate protection...
Conference Coverage
IDWEEK: Smother and pull, but don’t chop – how to identify and remove botfly larvae
Identifying a botfly infestation can be the toughest part of treating it.
News
Drug-resistant malaria parasite may spread to Africa
Artemisinin-resistant forms of Plasmodium falciparum parasites successfully infected various species of mosquitoes, including the major African...
News
Ebola virus may persist in semen 9 months after symptom onset
Male Ebola virus disease survivors may have viable Ebola virus RNA in their semen 9 months after the onset of symptoms.
News
Oral H. pylori vaccine found effective, safe
Key clinical point: For the first time, an oral vaccine against H. pylori infection proved effective and safe in a phase III trial. Major finding...